The projects will happen in 14 Member States and the United Kingdom, with €36 million in funding to get COVID-19 plasma to patients – boosting their immune response to the virus
The Emergency Support Instrument of the EU is the funding body for fighting COVID-19, which enabled the bloc to advance purchase vaccines and is behind efforts to link national Test and Trace Apps for increased protection.
Why is COVID-19 plasma important?
While it is not a cure, plasma is a crucial helper in the fight against COVID-19.
Plasma is the light yellow substance that makes up roughly 55% of your blood. It is mostly water, but it carries the antibodies that your body makes in response to any virus. The antibodies remain in your plasma for an unknown but crucial amount of time. Vaccine testing is heavily reliant on how the survivors have survived, working backward from that desired outcome.
Convalescent plasma is the attempt to transfer those biologically-equipped fighters from a successful war to a struggling battlefield, via blood transfusion to patients suffering severe COVID.
Medicinal companies are now able to purify antibodies from the plasma, to create immunoglobin.
The antibodies created by the virus fell by over half once six months had passed, in almost all the patients (94%), according to research released today by The Lancet. This means that it is more urgent to access plasma with antibodies as soon as possible.
What will the projects do?
Editor's Recommended Articles
Must Read >> UK approves Moderna COVID vaccine for use